DGFT extends last date for implementation of track and trace system for exports of drug formulations till April 1 next year
India: The Directorate General of Foreign Trade (DGFT) has once again extended the last date for implementation of track and trace system for exports of drug formulations till April 1 next year. The decision is applicable for both Small Scale Industries (SSI) and non SSI manufactured drugs. In a notification, DGFT said “The date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal has been extended up to April 1, 2020 for both SSI and non SSI manufactured drugs.” Under track and trace system, manufacturers or the exporters of drug formulations are required to print the barcode as per GSI Global Standard at different packaging levels to facilitate tracking and tracing of their products. The manufacturer or exporter shall maintain the data in the parent-child relationship for three levels of packaging i.e. Primary, Secondary and Tertiary packaging and their movement in its supply chain.

Read also;









ASPA all set to launch a new fight against counterfeiting in India
Authentication Solution Providers’ Association (ASPA) and CSIR – NIIST (National Institute for Interdisciplinary Science and Technology, Ministry of Science and Technology, Government of India) have agreed to join hands after signing a MoU for knowledge sharing, research and development of new generation Physical and Digital Authentication Solutions to support Make in India program and strengthening India’s position as a global leader in fight against counterfeit goods and products. Pooling in their resources together both these pioneering organizations can progress rapidly on India’s fight against counterfeiting. The decision was taken in the recently concluded Annual General Meeting (AGM) of ASPA. More info:  click here
Dubai turns to AI to combat counterfeiting
The Commercial Compliance & Consumer Protection (CCCP) Sector in Dubai Economy has announced that it will be adopting a new technology based on artificial intelligence (AI) to fight counterfeiting in Dubai. Developed by the US company ‘Entrupy,’ the new technology will help detect counterfeit goods sold across shops in the emirate. The new technology is being adopted in line with the directive of Sheikh Mohammed bin Rashid Al Maktoum to integrate artificial intelligence in the pursuit of excellence across government services and as part of the strategic objective of Dubai Economy to enhance competitiveness and sustainability through protecting the rights of consumers and trademark owners. More info:  click here
ISI's counterfeiting web targets India's Rs 100 notes
There has been increasing unease over a counterfeiting threat to an earlier series of Rs 100 notes in the post-demonetisation period. However, freshly minted Rs 2,000 and Rs 500 Fake Indian Currency Notes (FICNs) detected in the banking channel last year are of low quality, reveals an intelligence analysis. While suggesting more sophisticated security features for Rs 100 notes, the Central Economic Intelligence Bureau has asked the Reserve Bank of India (RBI) to adopt more effective anti-counterfeiting measures with the highest security features and texture in printing currency. It has also called for strengthening counterfeit detection systems at banks. More info:  click here
Latest Authentication & Traceability Tender
Latest anti-counterfeiting tender
Counterfeit Index
Regulatory updates
other leading news...
Tyre Association trial traceability technology
United Kingdom: The Tyre Recovery Association (TRA) announced the successful completion of a digital tyre tracking trial. Conducted with TRA member, Fraser Evans & Sons Ltd , and technology partner PragmatIC , the trial used Radio-Frequency Identification (RFID) tags. The tags are fixed to the tyre by the collector, who assigns them to their future use, for example retreading or reprocessing. For more click here
FDA to launch pilot blockchain network with IBM, KPMG, Walmart and Merck for drugs traceability
The US Food and Drug Administration (FDA) earlier this month selected IBM, Merck, KPMG and Walmart to participate in a pilot programme to create a proof-of-concept blockchain network to enhance the security of drugs supply chain, as per a joint release by the companies. The pilot has been authorised under the US Drug Supply Chain Security Act (DSCSA), which aims to establish a regulatory oversight framework to regulate counterfeit, stolen, contaminated, or otherwise harmful drugs. For more click here
NextFlex Launches $10.5M Funding Round for Anti-Counterfeiting, Flex Batteries and Hypersonics Innovation
 NextFlex, America’s Flexible Hybrid Electronics (FHE) Manufacturing Institute, released Project Call 5.0 (PC 5.0) — the latest call for proposals to fund projects that seek to further the development and adoption of FHE. Project Call 5.0 focuses on challenges related to scalable manufacturing and application-driven manufacturing gaps that have been prioritized by the community across a wide range of application areas — from anti-counterfeiting to structural health monitoring to hypersonics. For more click here
ASPA in News
Upcoming Industry Events